These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 18718742

  • 1. Recommendations to achieve rapid therapeutic teicoplanin plasma concentrations in adult hospitalised patients treated for sepsis.
    Brink AJ, Richards GA, Cummins RR, Lambson J, Gauteng Understanding Teicoplanin Serum levels (GUTS) study group.
    Int J Antimicrob Agents; 2008 Nov; 32(5):455-8. PubMed ID: 18718742
    [Abstract] [Full Text] [Related]

  • 2. Loading dose required to achieve rapid therapeutic teicoplanin trough plasma concentration in patients with multidrug-resistant gram-positive infections.
    Wang JT, Liao HI, Wu Lin FL, Chang SC.
    Basic Clin Pharmacol Toxicol; 2012 May; 110(5):416-20. PubMed ID: 22309355
    [Abstract] [Full Text] [Related]

  • 3. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
    Cepeda JA, Whitehouse T, Cooper B, Hails J, Jones K, Kwaku F, Taylor L, Hayman S, Shaw S, Kibbler C, Shulman R, Singer M, Wilson AP.
    J Antimicrob Chemother; 2004 Feb; 53(2):345-55. PubMed ID: 14711840
    [Abstract] [Full Text] [Related]

  • 4. Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose.
    Pea F, Brollo L, Viale P, Pavan F, Furlanut M.
    J Antimicrob Chemother; 2003 Apr; 51(4):971-5. PubMed ID: 12654757
    [Abstract] [Full Text] [Related]

  • 5. Teicoplanin levels in bone and joint infections: are standard doses subtherapeutic?
    Matthews PC, Taylor A, Byren I, Atkins BL.
    J Infect; 2007 Nov; 55(5):408-13. PubMed ID: 17825421
    [Abstract] [Full Text] [Related]

  • 6. Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections.
    Wilcox M, Nathwani D, Dryden M.
    J Antimicrob Chemother; 2004 Feb; 53(2):335-44. PubMed ID: 14729745
    [Abstract] [Full Text] [Related]

  • 7. Significance of individual adjustment of initial loading dosage of teicoplanin based on population pharmacokinetics.
    Niwa T, Imanishi Y, Ohmori T, Matsuura K, Murakami N, Itoh Y.
    Int J Antimicrob Agents; 2010 May; 35(5):507-10. PubMed ID: 20185275
    [Abstract] [Full Text] [Related]

  • 8. Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?
    Roberts JA, Roberts MS, Robertson TA, Dalley AJ, Lipman J.
    Crit Care Med; 2009 Mar; 37(3):926-33. PubMed ID: 19237898
    [Abstract] [Full Text] [Related]

  • 9. [The use of teicoplanin for Gram-positive infections in patients with kidney transplantation].
    Jákics J, Gálffy Z, Hernold L, Rácz A, Perner F.
    Orv Hetil; 1996 Jun 23; 137(25):1355-8. PubMed ID: 8757082
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Role of teicoplanin in the ambulatory treatment of infections in children due to gram-positive microorganisms].
    Debbag R, Paganini H, Gómez S, Casimir L, Stamboulian D.
    Medicina (B Aires); 2002 Jun 23; 62 Suppl 2():48-51. PubMed ID: 12481489
    [Abstract] [Full Text] [Related]

  • 12. [Efficacy of teicoplanin in 25 cases of severe infections caused by gram-positive cocci].
    Potel G, Touzé MD, Meignier M, Reynaud A, Baron D.
    Pathol Biol (Paris); 1988 May 23; 36(5):531-5. PubMed ID: 2970058
    [Abstract] [Full Text] [Related]

  • 13. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.
    Adembri C, Fallani S, Cassetta MI, Arrigucci S, Ottaviano A, Pecile P, Mazzei T, De Gaudio R, Novelli A.
    Int J Antimicrob Agents; 2008 Feb 23; 31(2):122-9. PubMed ID: 18055183
    [Abstract] [Full Text] [Related]

  • 14. Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.
    Portolés A, Palau E, Puerro M, Vargas E, Picazo JJ.
    Rev Esp Quimioter; 2006 Mar 23; 19(1):65-75. PubMed ID: 16688294
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
    Markou N, Markantonis SL, Dimitrakis E, Panidis D, Boutzouka E, Karatzas S, Rafailidis P, Apostolakos H, Baltopoulos G.
    Clin Ther; 2008 Jan 23; 30(1):143-51. PubMed ID: 18343250
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High-dose regimen to achieve novel target trough concentration in teicoplanin.
    Ueda T, Takesue Y, Nakajima K, Ichki K, Wada Y, Komatsu M, Tsuchida T, Takahashi Y, Ishihara M, Kimura T, Uchino M, Ikeuchi H.
    J Infect Chemother; 2014 Jan 23; 20(1):43-7. PubMed ID: 24462424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.